MicroPort Scientific (HK:0853) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MicroPort Scientific’s affiliate, Shanghai MicroPort Endovascular MedTech (EV MedTech), has reported a significant increase in financial performance for the first half of 2024, with a 26.63% jump in revenue and a 44.60% rise in profit compared to the same period in 2023. These results reflect only EV MedTech’s operations and are not indicative of MicroPort Scientific’s entire group performance. Investors are advised to exercise caution when trading company securities.
For further insights into HK:0853 stock, check out TipRanks’ Stock Analysis page.